Unlocking Novel Chemistry
Designing Better Therapeutics

Ansaris was established in February 2009 to focus on small molecule drug discovery challenges by leveraging 10 years of drug discovery expertise:

Fragment-based drug design technology from Sarnoff Corporation
Protein modeling technology from Protein Mechanics, Inc
Evolution of technologies into next generation and advancement of drug candidates into development from Locus Pharmaceuticals

GTCbio 6th Annual Protein Kinases in Drug Discovery

World Molecular Engineering Network Twenty-first Annual Meeting

CHI Fourth Annual Protein-Protein Interactions as Drug Targets

CHI Sixth Annual Fragment-Based Drug Discovery

ANSARIS RECEIVES MILESTONE PAYMENT FROM ONO UNDER DRUG DISCOVERY COLLABORATION

ANSARIS ANNOUNCES NEW SCIENTIFIC ADVISORS

ANSARIS ELECTS INDEPENDENT DIRECTOR TO BOARD